Exhibit 99.1 Southland Announces Second Quarter 2025 Results GRAPEVINE, Texas, August 12, 2025 -- Southland Holdings, Inc. (NYSE American: SLND and SLND WS) ("Southland"), a leading provider of specialized infrastructure construction services, today announced financial results for the quarter ended June 30, 2025. "We continue to be encouraged by the sustained margin improvement in our core business resulting from our disciplined approach to bidding and operations," said Frank Renda, Southland's President & ...

Exhibit 99.1 Southland Announces Second Quarter 2025 Results GRAPEVINE, Texas, August 12, 2025 -- Southland Holdings, Inc. (NYSE American: SLND and SLND WS) ("Southland"), a leading provider of specialized infrastructure construction services, today announced financial results for the quarter ended June 30, 2025. "We continue to be encouraged by the sustained margin improvement in our core business resulting from our disciplined approach to bidding and operations," said Frank Renda, Southland's President & ...

CAVA GROUP REPORTS SECOND QUARTER 2025 RESULTS YEAR OVER YEAR CAVA REVENUE GROWTH OF 20.3% INCLUDING CAVA SAME RESTAURANT SALES GROWTH OF 2.1% 16 NET NEW CAVA RESTAURANT OPENINGS DURING QUARTER SECOND QUARTER 2025 CAVA RESTAURANT-LEVEL PROFIT MARGIN OF 26.3% WASHINGTON, D.C. (August 12, 2025) - CAVA Group, Inc. (NYSE: CAVA) ("CAVA Group" or the "Company"), the category- defining Mediterranean fast-casual restaurant brand that brings heart, health, and humanity to food, today announced financial results for ...

Everus Reports Second Quarter Results, Raises Guidance for 2025 BISMARCK, N.D. — Aug. 12, 2025 — Everus Construction Group (NYSE: ECG) today reported financial results for second quarter 2025. Second Quarter 2025 Summary (all comparisons versus the prior-year period unless otherwise noted, and results denoted with * are quarterly records) See the Non-GAAP Measures sections for definitions and reconciliations of the non-GAAP financial measures used in this news release. Management Commentary "We are extremel ...

Exhibit 99.1 NEWS RELEASE FOR IMMEDIATE RELEASE TEAM, INC. REPORTS SECOND QUARTER 2025 RESULTS SUGAR LAND, Texas, August 12, 2025 – Team, Inc. (NYSE: TISI) ("TEAM" or the "Company"), a global, leading provider of specialty industrial services offering customers access to a full suite of conventional, specialized, and proprietary mechanical, heat-treating, and inspection services, today reported its financial results for the quarter ended June 30, 2025. Second Quarter 2025 Highlights: See the accompanying re ...

Inclusive of $0.2 million, or $0.01 per weighted-average common share, of capital gains-based incentive fees reversed during the three months ended June 30, 2025 and $2.1 million, or $0.06 per weighted-average common share, of capital gains-based incentive fees accrued during the three months ended March 31, 2025, respectively. These fees were accrued in accordance with United States generally accepted accounting principles ("U.S. GAAP"), where such amounts were not contractually due under the terms of the ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-00100 TherapeuticsMD, Inc. (Exact name of Registrant as specified in its Charter) Nevada 87-0233535 (State or other jurisdiction ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________________________________________________________________________ FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-08604 TEAM, INC. (Registrant's T ...

Fintech部门收入表现 - 公司Fintech部门2025年第二季度收入为637.8万美元，同比增长420万美元，主要由于2024年5月收购ALT5 Subsidiary及2025年5月收购Mswipe[178][186] - 公司Fintech部门2025年26周收入1.189亿美元，占公司总收入100%，运营亏损144.2万美元[200][199] - 公司2025年26周总收入为1.189亿美元，较2024年同期增长970万美元，主要由于ALT5 Subsidiary和Mswipe的收购[193] Fintech部门利润及毛利率 - Fintech部门毛利率从2024年的50.6%下降至2025年的43.5%，毛利润增长170万美元至277.5万美元[177][179] - 2025年第二季度Fintech部门运营亏损107.9万美元，较2024年同期盈利26.1万美元显著恶化[185][186] - 公司2025年26周毛利润为5366万美元，毛利率45.1%，较2024年同期增长550万美元[194][192] 公司整体净亏损 - 公司整体净亏损从2024年的盈利58.9万美元恶化至2025年亏损911.5万美元，主要因Fintech运营亏损107.9万美元及Biotech部门停业亏损361.3万美元[175][185] - 公司2025年26周净亏损1.1976亿美元，较2024年同期扩大1.0421亿美元[190] 调整后EBITDA - 调整后EBITDA亏损从2024年的91.7万美元扩大至2025年的129.1万美元，Fintech部门EBITDA利润率从22.4%转为-3.1%[175] - 公司2025年26周调整后EBITDA为-2331万美元，占收入比例为-19.6%，较2024年同期下降34%[190][204] 销售及行政费用 - 销售及行政费用增长150万美元至487万美元，主要来自新收购业务[180][185] - 公司2025年26周销售及行政费用为9091万美元，较2024年同期增加450万美元[195] 利息支出 - 利息净支出增加56万美元至55万美元，源于ALT5 Subsidiary收购相关债务[181] - 公司2025年26周净利息支出为1270万美元，较2024年同期增加100万美元[196] Biotech部门表现 - Biotech部门（Alyea）已列为停业业务，2025年第二季度税后亏损361.3万美元，计划于2025年6月2日完成分拆[173][188] 现金及现金流 - 公司现金及等价物未披露具体数字，但强调非GAAP指标Adjusted EBITDA用于评估运营能力和债务偿付能力[172][174] - 截至2025年6月28日，公司现金持有量为960万美元[205] - 公司2025年26周经营活动现金流出670万美元，较2024年同期增加624万美元[207] - 公司2025年26周融资活动现金流入370万美元，2024年同期为现金流出120万美元[209] 其他财务数据 - 未实现证券亏损18万美元仅出现在2024年报表中，与GeoTraq出售交易相关[182]

United States SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-37716 Stratus Properties Inc. (Exact name of registrant as specified in its charter) Delaware 72-1211572 incorporation or organi ...